文献
J-GLOBAL ID:202102235362075646
整理番号:21A0038965
ソフォリコシドは,マウスの脂肪肝に対する強力な治療効果を有する選択的LXRβアンタゴニストである【JST・京大機械翻訳】
Sophoricoside is a selective LXRβ antagonist with potent therapeutic effects on hepatic steatosis of mice
著者 (13件):
Zhang Yu
(School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Zhang Yu
(School of Life Science and Technology, Shanghai Tech University, Shanghai, China)
,
Li Fei
(School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Jiang Xi
(School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Jiang Xiqian
(Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA)
,
Wang Yahui
(School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Zhang Haiyan
(Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Zhang Li
(Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Fan Shengjie
(School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Xin Lianjun
(Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Yang Baican
(School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Ji Guang
(Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
,
Huang Cheng
(School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China)
資料名:
Phytotherapy Research
(Phytotherapy Research)
巻:
34
号:
12
ページ:
3168-3179
発行年:
2020年
JST資料番号:
W0135A
ISSN:
0951-418X
CODEN:
PHYREH
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)